ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 134 filers reported holding ANAPTYSBIO INC in Q2 2024. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $35,695,615 | +17.1% | 1,424,406 | +5.2% | 0.00% | 0.0% |
Q1 2024 | $30,492,147 | +3.1% | 1,354,003 | -1.9% | 0.00% | 0.0% |
Q4 2023 | $29,562,063 | -3.3% | 1,380,115 | -18.9% | 0.00% | 0.0% |
Q3 2023 | $30,581,946 | -15.3% | 1,702,781 | -4.1% | 0.00% | 0.0% |
Q2 2023 | $36,117,677 | -8.8% | 1,775,697 | -2.4% | 0.00% | 0.0% |
Q1 2023 | $39,584,182 | -28.1% | 1,819,126 | +2.4% | 0.00% | 0.0% |
Q4 2022 | $55,066,379 | +23.7% | 1,776,908 | +1.8% | 0.00% | 0.0% |
Q3 2022 | $44,518,000 | +26.7% | 1,745,108 | +0.8% | 0.00% | 0.0% |
Q2 2022 | $35,129,000 | -22.3% | 1,730,470 | -5.3% | 0.00% | 0.0% |
Q1 2022 | $45,208,000 | -29.4% | 1,827,314 | -0.8% | 0.00% | 0.0% |
Q4 2021 | $64,032,000 | +29.1% | 1,842,683 | +0.7% | 0.00% | 0.0% |
Q3 2021 | $49,609,000 | +1.5% | 1,829,230 | -2.9% | 0.00% | 0.0% |
Q2 2021 | $48,855,000 | -2.5% | 1,884,141 | -18.9% | 0.00% | 0.0% |
Q1 2021 | $50,089,000 | +4.9% | 2,324,259 | +4.7% | 0.00% | 0.0% |
Q4 2020 | $47,737,000 | +56.8% | 2,220,321 | +7.6% | 0.00% | 0.0% |
Q3 2020 | $30,445,000 | -39.6% | 2,064,077 | -8.5% | 0.00% | -50.0% |
Q2 2020 | $50,390,000 | +52.0% | 2,255,580 | -3.9% | 0.00% | +100.0% |
Q1 2020 | $33,152,000 | -7.0% | 2,346,214 | +6.9% | 0.00% | 0.0% |
Q4 2019 | $35,664,000 | -53.9% | 2,194,661 | -0.8% | 0.00% | -66.7% |
Q3 2019 | $77,442,000 | -30.9% | 2,213,233 | +11.5% | 0.00% | -25.0% |
Q2 2019 | $112,001,000 | -20.1% | 1,985,144 | +3.4% | 0.00% | -33.3% |
Q1 2019 | $140,228,000 | +16.4% | 1,919,617 | +1.6% | 0.01% | +20.0% |
Q4 2018 | $120,513,000 | -34.8% | 1,889,201 | +2.0% | 0.01% | -28.6% |
Q3 2018 | $184,767,000 | +68.5% | 1,851,930 | +20.0% | 0.01% | +40.0% |
Q2 2018 | $109,645,000 | -16.0% | 1,543,413 | +23.0% | 0.01% | -16.7% |
Q1 2018 | $130,580,000 | +42.4% | 1,254,621 | +37.8% | 0.01% | +50.0% |
Q4 2017 | $91,713,000 | +516.0% | 910,570 | +113.8% | 0.00% | +300.0% |
Q3 2017 | $14,888,000 | +201.9% | 425,986 | +106.8% | 0.00% | – |
Q2 2017 | $4,931,000 | +5.7% | 206,031 | +22.6% | 0.00% | – |
Q1 2017 | $4,665,000 | – | 168,099 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $53,362,000 | 8.10% |
EcoR1 Capital, LLC | 7,521,024 | $152,677,000 | 5.27% |
GREAT POINT PARTNERS LLC | 453,118 | $9,198,000 | 2.21% |
Soleus Capital Management, L.P. | 643,575 | $13,065,000 | 2.04% |
Frazier Life Sciences Management, L.P. | 899,700 | $18,264,000 | 1.72% |
Boxer Capital, LLC | 1,300,000 | $26,390,000 | 1.67% |
Deep Track Capital, LP | 672,569 | $13,653,000 | 0.90% |
Palo Alto Investors LP | 431,024 | $8,750,000 | 0.76% |
TCG Crossover Management, LLC | 58,515 | $1,188,000 | 0.50% |
HighVista Strategies LLC | 33,103 | $672,000 | 0.41% |